Cardiff Oncology, Inc. (DE:XE7C)

Cardiff Oncology (XE7C) Financial Statements


Cardiff Oncology Financial Overview

Cardiff Oncology's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Cardiff Oncology is scheduled to report earnings on February 29, 2024, and the estimated EPS forecast is €-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 141.00K$ 108.00K$ 83.00K$ 128.00K$ 93.00K
Gross Profit$ 141.00K$ 108.00K$ 83.00K$ 128.00K-
EBIT$ -9.73M$ -11.15M$ -11.22M$ -10.28M$ -8.99M
EBITDA$ -9.94M$ -11.29M$ -11.30M$ -10.23M$ -8.91M
Net Income Common Stockholders$ -9.74M$ -11.16M$ -11.23M$ -8.70M$ -8.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 81.36M$ 89.43M$ 96.97M$ 105.27M$ 114.30M
Total Assets$ 88.45M$ 97.45M$ 106.55M$ 116.19M$ 123.63M
Total Debt$ 2.29M$ 2.44M$ 2.58M$ 2.71M$ 2.85M
Net Debt$ -79.07M$ -86.99M$ -94.39M$ -102.55M$ -111.45M
Total Liabilities$ 10.63M$ 10.88M$ 10.05M$ 116.19M$ 10.42M
Stockholders Equity$ 77.83M$ 86.58M$ 96.50M$ 106.34M$ 113.21M
Cash Flow-
Free Cash Flow$ -8.27M$ -7.38M$ -8.67M$ -9.46M$ -7.93M
Operating Cash Flow$ -7.96M$ -7.13M$ -8.66M$ -9.39M$ -7.49M
Investing Cash Flow$ 3.82M$ 11.48M$ 7.33M$ 7.02M$ 5.16M
Financing Cash Flow----$ 75.00K
Currency in USD

Cardiff Oncology Earnings and Revenue History

Cardiff Oncology Debt to Assets

Cardiff Oncology Cash Flow

Cardiff Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis